InfuSystem Holdings Inc (NYSEAMERICAN:INFU) CEO Richard Dilorio purchased 3,900 shares of the firm’s stock in a transaction dated Monday, March 11th. The shares were bought at an average price of $4.22 per share, with a total value of $16,458.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Shares of NYSEAMERICAN INFU traded down $0.02 during trading hours on Thursday, hitting $4.22. 309 shares of the company’s stock were exchanged, compared to its average volume of 22,965. InfuSystem Holdings Inc has a 1-year low of $2.25 and a 1-year high of $4.30.
InfuSystem (NYSEAMERICAN:INFU) last posted its quarterly earnings data on Thursday, March 7th. The medical instruments supplier reported ($0.01) earnings per share for the quarter. The company had revenue of $17.56 million during the quarter.
COPYRIGHT VIOLATION NOTICE: “InfuSystem Holdings Inc (INFU) CEO Richard Dilorio Acquires 3,900 Shares of Stock” was originally published by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://dakotafinancialnews.com/2019/03/14/infusystem-holdings-inc-infu-ceo-richard-dilorio-acquires-3900-shares-of-stock.html.
InfuSystem Company Profile
InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Further Reading: What is Cost of Capital?
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.